Key Clinical Points Rapid Diagnostic Testing for SARS-CoV-2 Rapid diagnostic tests (RDTs)
that are authorized by the Food and Drug Administration to diagnose severe acute …

Testing for SARS-CoV-2: Can We Stop at 2? | Clinical Infectious Diseases | Oxford Academic
Skip to Main Content Advertisement Oxford Academic Journals Books Search Menu Information …

Diagnostic testing for SARS-CoV-2 is a critical component to the overall prevention and
control strategy for COVID-19. Countries should have a national testing strategy in place …

Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical …

This document provides interim guidance to laboratories and other stakeholders involved in
diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It covers …

Background High-throughput assays for the SARS-CoV-2 virus are critical to increasing test
capacity and slowing the spread of COVID-19. Abbott Molecular developed and received …

Controversies over diagnostic testing have dominated US headlines about severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus responsible for …

Background Since the beginning of the COVID-19 pandemic, laboratories have been using
nucleic acid amplification tests (NAATs), such as real time reverse transcription polymerase …

Background Many commercial assays, of different designs, detecting SARS-CoV-2-specific
antibodies exist but with little experience with them. Objectives The aim of this study was to …

False Negative Tests for SARS-CoV-2 Infection Diagnostic testing for SARS-CoV-2 will help
in safely reopening the country, but only if tests are highly accurate. Several steps need to …